Preservation of compound integrity under degradation-inducing conditions
Held under heat, light, oxidation and pH stress, the stabilized compound retains its structure through the evaluation period.
Pharmaceutical Integrity
Platform
Two licensable systems. One holds the molecule stable, the other holds its identity across the supply chain.
Two core challenges limiting pharmaceutical success
Performance variability
Molecular instability
Inconsistent pharmacokinetics
Variable clinical outcomes
Difficulty in FDA study replication
Integrity and trust gaps
Counterfeit and diverted products
Lack of product-level verification
Undetected tampering or handling failures
Fragmented supply chain visibility
A unified approach
One licensing platform that resolves both challenges.
Two complementary systems, deployed independently or integrated, hold consistency from formulation through patient use.
Two systems. Independent or integrated.
Each system licenses on its own. Together they cover how a product performs and whether it can be trusted.
Stabilization: performance integrity.
Preserves molecular structure and function, for more predictable performance and less variability in clinical outcomes.
Product Integrity: verification and trust.
Establishes persistent product identity, for verified authenticity, reduced counterfeit risk, and improved compliance.
Extraction: qualified isolation.
Method-matched isolation sets the ceiling for everything downstream, because no formulation restores what extraction lost.
Precision Analytics: structured proof.
Compound integrity, active concentration, and carrier performance verified at every stage, so claims arrive with data.
Validation
Internal validation has demonstrated consistent and repeatable performance across controlled evaluation environments relevant to pharmaceutical applications.
Improved consistency in pharmacokinetic-related outcomes
Release and uptake behavior stays within a tighter band across repeat runs rather than varying batch to batch.
Reliable detection of controlled inconsistencies in product identity
Deliberately altered and substituted units were identified at the product level during controlled evaluation.
Repeatable system behavior across varied test conditions
The same result holds when conditions, operators and equipment change, which is what makes the method transferable.
Maintained biological performance over extended timeframes
Functional activity is preserved across extended timepoints, not only at the moment of formulation.
Performance + Trust Across the Lifecycle
When deployed together, the two systems create a unified Pharmaceutical Integrity Platform addressing both core dimensions of pharmaceutical reliability.
End-to-end consistency
From formulation through patient use, both performance and identity are maintained.
Reduced variability
Stabilization reduces pharmacokinetic variability while integrity systems reduce supply chain risk.
Increased confidence
Partners, regulators, and patients gain confidence in both what the product does and what it is.
Request technical materials.
Detailed technical information, validation data, and platform architecture are available under appropriate confidentiality agreements.
Platform questions
Yes. Each is designed to deliver standalone value. Stabilization can be independently licensed for drug development programs. Product Integrity can be independently deployed across manufacturing and distribution systems.
When deployed together, the platform provides end-to-end consistency from formulation through patient use, addressing both performance integrity and product integrity across the pharmaceutical lifecycle.
Internal validation has demonstrated preservation of compound integrity under degradation-inducing conditions, improved consistency in pharmacokinetic-related outcomes, reliable detection of controlled inconsistencies, and repeatable system behavior across varied test conditions.
Detailed technical information, validation data, and platform architecture are available under appropriate confidentiality agreements. Use the Contact page to request access.